Farwell Wildon (CIK 0001847941)

Latest company ownership

Role: Chief Medical Officer
Shares held
143,222
Last filed at
Aug 20, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 19, 2024 Aug 20, 2024 Dyne Therapeutics, Inc. Chief Medical Officer Sell 45.0 -2,321 -1.59% $104.7K
Jun 11, 2024 Jun 11, 2024 Dyne Therapeutics, Inc. Chief Medical Officer Sell 45.0 -2,636 -1.78% $82.4K
May 16, 2024 May 17, 2024 Dyne Therapeutics, Inc. Chief Medical Officer Sell 45.0 -2,381 -1.58% $67.3K
Mar 11, 2024 Mar 12, 2024 Dyne Therapeutics, Inc. Chief Medical Officer Sell 45.0 -2,615 -1.71% $67.1K
Mar 7, 2024 Mar 11, 2024 Dyne Therapeutics, Inc. Chief Medical Officer Sell 30.0 -9,921 -6.08% $256.6K
Feb 28, 2024 Feb 28, 2024 Dyne Therapeutics, Inc. Chief Medical Officer Sell 53.8 -407 -0.25% $10.2K
Feb 12, 2024 Feb 14, 2024 Dyne Therapeutics, Inc. Chief Medical Officer Sell 37.5 -5,493 -3.25% $137.7K
Jan 26, 2024 Jan 26, 2024 Dyne Therapeutics, Inc. Chief Medical Officer Sell 56.3 -100 -0.06% $2.5K
Dec 11, 2023 Dec 12, 2023 Dyne Therapeutics, Inc. Chief Medical Officer Sell 48.8 -2,666 -1.55% $28.4K
Sep 12, 2023 Sep 13, 2023 Dyne Therapeutics, Inc. Chief Medical Officer Sell 48.8 -1,707 -1.88% $17.8K
Jun 13, 2023 Jun 14, 2023 Dyne Therapeutics, Inc. Chief Medical Officer Sell 48.8 -1,698 -1.83% $21.1K
Mar 14, 2023 Mar 15, 2023 Dyne Therapeutics, Inc. Chief Medical Officer Sell 32.5 -7,441 -7.43% $99.2K
Dec 9, 2022 Dec 13, 2022 Dyne Therapeutics, Inc. Chief Medical Officer Sell 90.0 +35,372 54.65% $6.8K
Sep 15, 2022 Sep 15, 2022 Dyne Therapeutics, Inc. Chief Medical Officer Sell 50.0 -658 -1.01% $9.2K
Jun 14, 2022 Jun 15, 2022 Dyne Therapeutics, Inc. Chief Medical Officer Sell 50.0 -668 -1.01% $3.3K
Mar 11, 2022 Mar 14, 2022 Dyne Therapeutics, Inc. Chief Medical Officer Sell 52.5 -640 -0.96% $5.6K
Mar 2, 2022 Mar 3, 2022 Dyne Therapeutics, Inc. Chief Medical Officer Sell 32.5 -5,617 -7.77% $48.1K